tafenoquine has been researched along with Malaria, Falciparum in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 10 (41.67) | 29.6817 |
| 2010's | 9 (37.50) | 24.3611 |
| 2020's | 4 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
| Iyer, PS; Kannan, M; Khan, FR; Raichurkar, AV | 1 |
| Attaher, O; Bousema, T; Bradley, J; Diallo, M; Dicko, A; Dicko, OM; Drakeley, C; Issiaka, D; Keita, S; Lanke, K; Maguiraga, SO; Mahamar, A; McCall, MBB; Niambele, SM; Sacko, A; Samake, S; Sanogo, K; Sinaba, Y; Smit, MJ; Stone, W; Ter Heine, R; Traore, SF | 1 |
| White, NJ | 1 |
| Abd-Rahman, AN; Barber, BE; Birrell, GW; Edstein, MD; Leelasena, I; Llewellyn, S; Marquart, L; McCarthy, JS; Moehrle, JJ; Potter, AJ; Sahai, N; Shanks, GD; Webster, R; Wesche, D | 1 |
| Contreras-Mancilla, J; Delgado-Ratto, C; Fernandez-Miñope, C; Ferrucci, HR; Gamboa, D; Llanos-Cuentas, A; Van Geertruyden, JP | 1 |
| Dow, G; Smith, B | 1 |
| Berman, J; Dobbin, C; Dow, GS; Marquart, L; McCarthy, JS; Read, LT; Reid, M; Smith, B; West, L | 1 |
| Berman, JD | 1 |
| Dow, GS; McCarthy, WF; Reid, M; Shanks, GD; Smith, B; Tang, D | 1 |
| Dow, GS; Hetzell, B; Lin, G; Liu, J; McCarthy, WF; Smith, B; Tang, D; Thieling, S | 1 |
| Kaewpruk, N; Mungthin, M; Sitthichot, N; Suwandittakul, N; Tan-ariya, P; Ward, SA | 1 |
| Gbotosho, GO; Happi, CT; Okuboyejo, TM; Sowunmi, A | 1 |
| Adjuik, M; Baird, JK; Binka, FN; Franke, ED; Fryauff, DJ; Hale, BR; Hoffman, SL; Horton, J; Koram, KA; Nkrumah, F; Oduro, AR; Owusu-Agyei, S; Prescott, WR; Ritchie, TL | 1 |
| Peters, W; Robinson, BL; Stewart, LB | 1 |
| Brewer, TG; Cherdchu, C; Eamsila, C; Edstein, MD; Jarasrumgsichol, P; Khaewsathien, P; Rieckmann, KH; Sangkharomya, S; Sasiprapha, T; Supakalin, P; Tang, DB; Walsh, DS | 1 |
| Prajakwong, S; Sirichaisinthop, J; Vollnberg, A; Wernsdorfer, G; Wernsdorfer, WH; Wiedermann, G | 1 |
| Czarnecki, E; Fusai, T; Koeck, JL; Kombila, M; Mamfoumbi, MM; Mosnier, J; Pradines, B; Rogier, C; Sokhna, C; Spiegel, A; Tall, A; Trape, JF | 1 |
| Crockett, M; Kain, KC | 1 |
| Brueckner, RP; Coster, T; Schuster, BG; Shmuklarsky, M; Wesche, DL | 1 |
| Borrmann, S; Dangelmaier, O; Faucher, JF; Horton, J; Kremsner, PG; Lell, B; Missinou, MA | 1 |
| Eamsila, C; Edstein, MD; Kitchener, S; Nasveld, PE; Rieckmann, KH; Sasiprapha, T; Walsh, DS | 1 |
| Aleman, GM; Braitman, D; Brueckner, R; Horton, J; Klotz, FW; Ohrt, C; Oloo, AJ; Shanks, GD | 1 |
4 review(s) available for tafenoquine and Malaria, Falciparum
| Article | Year |
|---|---|
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
The blood schizonticidal activity of tafenoquine makes an essential contribution to its prophylactic efficacy in nonimmune subjects at the intended dose (200 mg).
Topics: Aminoquinolines; Animals; Antimalarials; Half-Life; Humans; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax; Schizonts | 2017 |
Tafenoquine: a promising new antimalarial agent.
Topics: Aminoquinolines; Animals; Antimalarials; Humans; Malaria, Falciparum; Malaria, Vivax; Recurrence; Treatment Outcome | 2007 |
Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force.
Topics: Aminoquinolines; Antimalarials; Australia; Controlled Clinical Trials as Topic; Endemic Diseases; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Military Personnel; Primaquine | 2001 |
9 trial(s) available for tafenoquine and Malaria, Falciparum
| Article | Year |
|---|---|
Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial.
Topics: Aminoquinolines; Animals; Artemisinins; Humans; Malaria; Malaria, Falciparum; Mali; Piperazines; Plasmodium falciparum; Quinolines; Single-Blind Method | 2022 |
Blood Schizonticidal Activity and Safety of Tafenoquine When Administered as Chemoprophylaxis to Healthy, Nonimmune Participants Followed by Blood Stage Plasmodium falciparum Challenge: A Randomized, Double-blind, Placebo-controlled Phase 1b Study.
Topics: Adult; Aminoquinolines; Antimalarials; Chemoprevention; Double-Blind Method; Female; Healthy Volunteers; Humans; Malaria, Falciparum; Male; Parasitemia; Placebos; Plasmodium falciparum; Schizonts; Young Adult | 2019 |
Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries.
Topics: Adolescent; Adult; Africa; Aminoquinolines; Antimalarials; Chemoprevention; Double-Blind Method; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Placebos; Treatment Outcome; Young Adult | 2015 |
A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
Topics: Adult; Aged; Aminoquinolines; Animals; Antimalarials; Chemoprevention; Double-Blind Method; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Treatment Outcome | 2003 |
Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria.
Topics: Administration, Oral; Aminoquinolines; Animals; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Multiple; Follow-Up Studies; Humans; Malaria, Falciparum; Malaria, Vivax; Military Personnel; Plasmodium falciparum; Thailand; Treatment Outcome | 2004 |
Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial.
Topics: Adult; Aminoquinolines; Animals; Antimalarials; Double-Blind Method; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum | 1998 |
Malaria chemoprophylaxis with tafenoquine: a randomised study.
Topics: Adolescent; Adult; Aminoquinolines; Antimalarials; Child; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Gabon; Humans; Malaria, Falciparum; Male; Phenanthrenes | 2000 |
Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force.
Topics: Aminoquinolines; Antimalarials; Australia; Controlled Clinical Trials as Topic; Endemic Diseases; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Military Personnel; Primaquine | 2001 |
A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Aminoquinolines; Animals; Antimalarials; Chemoprevention; Double-Blind Method; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Treatment Outcome | 2001 |
12 other study(ies) available for tafenoquine and Malaria, Falciparum
| Article | Year |
|---|---|
Synthesis and in vitro evaluation of novel 8-aminoquinoline-pyrazolopyrimidine hybrids as potent antimalarial agents.
Topics: Aminoquinolines; Antimalarials; Humans; Malaria, Falciparum; Molecular Docking Simulation; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Pyrimidines; Structure-Activity Relationship | 2015 |
The Antimalarial Activity of Tafenoquine in Falciparum Malaria.
Topics: Aminoquinolines; Antimalarials; Healthy Volunteers; Humans; Malaria, Falciparum; Plasmodium falciparum | 2023 |
Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Australia; Healthy Volunteers; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum | 2023 |
Towards one standard treatment for uncomplicated Plasmodium falciparum and Plasmodium vivax malaria: Perspectives from and for the Peruvian Amazon.
Topics: Adult; Aminoquinolines; Artemisinins; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Peru; Plasmodium falciparum; Plasmodium vivax; Prevalence; Primaquine; Reference Standards | 2021 |
Approval of Tafenoquine for Malaria Chemoprophylaxis.
Topics: Aminoquinolines; Antimalarials; Australia; Chemoprevention; Child; Contraindications, Drug; Drug Administration Schedule; Drug Approval; Female; Fetus; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Malaria, Falciparum; Methemoglobin; Pregnancy; Psychotic Disorders; United States | 2019 |
A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area.
Topics: Aminoquinolines; Antimalarials; Australia; Chemoprevention; Endemic Diseases; Humans; Incidence; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Military Personnel; Retrospective Studies; Timor-Leste; Travel; Treatment Outcome; United States | 2014 |
PFMDR1 POLYMORPHISMS INFLUENCE ON IN VITRO SENSITIVITY OF THAI PLASMODIUM FALCIPARUM ISOLATES TO PRIMAQUINE, SITAMAQUINE AND TAFENOQUINE.
Topics: Aminoquinolines; Antimalarials; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Primaquine; Thailand | 2016 |
Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children before and after artemisinin-based combination treatments.
Topics: Adolescent; Aminoquinolines; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Risk Factors | 2011 |
The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines.
Topics: Aminoquinolines; Animals; Antimalarials; Chloroquine; Disease Models, Animal; Drug Resistance; Drug Therapy, Combination; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Mice; Plasmodium berghei; Plasmodium chabaudi; Plasmodium yoelii; Primaquine; Time Factors | 2003 |
Molecule of the month. Tafenoquine succinate.
Topics: Aminoquinolines; Antimalarials; Drug Administration Schedule; Humans; Malaria, Falciparum; Randomized Controlled Trials as Topic | 2003 |
In-vitro interaction of tafenoquine and chloroquine in Plasmodium falciparum from northwestern Thailand.
Topics: Adolescent; Adult; Aminoquinolines; Animals; Antimalarials; Cell Proliferation; Chloroquine; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Humans; Malaria, Falciparum; Plasmodium falciparum; Species Specificity; Thailand | 2003 |
In vitro activity of tafenoquine against the asexual blood stages of Plasmodium falciparum isolates from Gabon, Senegal, and Djibouti.
Topics: Aminoquinolines; Animals; Antimalarials; Djibouti; Gabon; Humans; Malaria, Falciparum; Plasmodium falciparum; Senegal | 2006 |